Spravato®Registry-verifiedDesignated-centers model

Radboudumc

Nijmegen, Netherlands

Treatment & access

About this provider

Radboudumc (Radboud University Medical Center, Nijmegen) offers esketamine nasal spray treatment for severe unipolar, treatment-resistant depression through its Department of Psychiatry, on referral from a GP or psychiatrist. It is the national coordinator of the Esketamine Nasal Spray Consortium Netherlands (ENC-NL), which collects real-world treatment data across Dutch centres. Treatment follows a phased protocol (4 weeks twice-weekly titration, 4 weeks weekly optimisation, then a minimised maintenance frequency), always combined with an antidepressant. The department also runs rTMS, a Centre for Mindfulness (MBCT), pharmacogenetics-based personalised antidepressant advice, and a medical-psychiatric unit for complex cases.

Services & programs

  • Esketamine nasal spray for treatment-resistant unipolar depression (intake, phased treatment, regular evaluation with questionnaires)
  • rTMS (repetitive transcranial magnetic stimulation) for severe/treatment-resistant depression
  • Centre for Mindfulness - MBCT (reimbursed as part of treatment when a psychiatric disorder is present)
  • Personalised antidepressant advice with medication review and pharmacogenetics
  • Diagnostic outpatient clinic (diagnostics, treatment advice, second opinion); Medical Psychiatric Unit / High Intensive Care; addiction detoxification; dialectical schema therapy (DST) programme

Programs & studies

ProgramKindStatus
ENC-NL national real-world data collection on esketamine nasal spray (Radboudumc = national coordinator); patients asked consent for pseudonymised data useongoing
Esketamine reimbursed from basic package since 1 Sept 2021 for TRD after >=3 medication steps incl. >=1 augmentation; insurer authorisation (machtiging) copy required with referralactive

Pricing

ItemPrice
Esketamine treatment
no self-pay tariff published; declared as add-on within Zorgprestatiemodel (per ENC-NL)
covered by Dutch basic health insurance (Zorgverzekeringswet) for eligible TRD patients

Prices are taken from the provider's own website and were last checked on . Always confirm the current price with the provider before booking.

Facilities & languages

  • Facilities
    • Polikliniek Psychiatrie, Reinier Postlaan 4, Nijmegen (Ingang Oost, building N, floor 0, route 961)
    • Medical Psychiatric Unit (route 963), Neurobiological Treatment Unit (route 975), Centre for Mindfulness (route 974)
    • Facilities designed on 'healing environment' concept
  • LanguagesDutch (patient pages NL-only; hospital site has EN/DE sections)
  • TeamNamed contact for esketamine consultations: Dr. H.G. (Eric) Ruhe, psychiatrist. Department of Psychiatry with admission coordinators; team size not published on treatment pages.

Common questions

Do I need a referral?

Yes - referral by GP or treating psychiatrist is required (via ZorgDomein or referral letter with full treatment history and a copy of the insurer authorisation request).

Who is eligible?

(Severe) unipolar depression with no response to at least 3 pharmacological steps with antidepressants, of which at least 1 augmentation strategy (lithium, atypical antipsychotic or mirtazapine). Not eligible: bipolar depression, MI/CVA within 6 weeks, untreated unstable hypertension, pregnancy.

How does the treatment run?

Titration phase 2x/week for 4 weeks, evaluation, then optimisation 1x/week for 4 weeks if clearly improving, then maintenance at lowest possible frequency (1x/1-3 weeks). Always combined with an antidepressant; fast 2h (no food) / 30 min (no fluids) before sessions.

What about the waiting time?

After the indication intake the clinic tries to keep the wait until treatment as short as possible; current access times are published on the hospital's 'wachttijden psychiatrie' page.

Is it covered by insurance?

Yes - esketamine nasal spray is reimbursed from the Dutch basic package since 1 September 2021 for difficult-to-treat unipolar depression; it is dispensed only intramurally via the hospital pharmacy.

Verification

This record was taken directly from an official registry or program list and is re-checked on a rolling cadence.

Spotted an error? See our methodology for how records are checked and how to report a correction.